where to next?, page-815

I posted an identical post on MXC’s thread:

I thought I’d share this Australian Journal of Pharmacy (AJP) article with you all:

https://ajp.com.au/news/how-many-australians-are-accessing-unapproved-medicinal-cannabis/

Note: Although products that are obtained on the SAS scheme are ones that have not yet been approved by the TGA, their manufacturers would invariably possess at least one GMP licence. GMP licences are recognised globally. A GMP licence is a pre-requisite for SAS listings (i.e. Category A, Category B and Category C).

InX_